Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis

Clinical trial NCT01111123 · COMPLETED

Trial details

NCT number: NCT01111123
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2009-01-01
Primary completion: 2010-03-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.